Sirolimus and secondary skin-cancer prevention in kidney transplantation. - Wikidata - wikimedia - TriplyDB

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

http://www.wikidata.org/entity/Q55056496

about

Incidence, risk factors and outcomes of de novo malignancies post liver transplantation Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?Corticosteroid and calcineurin inhibitor sparing regimens in kidney transplantation A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients Reviewing 15 years of experience with sirolimus Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin HPV-related cancers after solid organ transplantation in the United States Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.The pros and the cons of mTOR inhibitors in kidney transplantation.From rapalogs to anti-aging formula.Hormesis and Defense of Infectious Disease.Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients Skin cancer in organ transplant recipients: more than the immune system.The cutting edge of skin cancer in transplant recipients: scientific retreat of international transplant Skin Cancer Collaborative and Skin Cancer in Organ Transplant Patients Europe Malignant and noninvasive skin tumours in renal transplant recipients Merkel cell carcinoma in immunosuppressed patients.Selective anti-cancer agents as anti-aging drugs A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients.Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.Premalignant and Malignant Skin Lesions in Two Recipients of Vascularized Composite Tissue Allografts (Face, Hands)Rejuvenating immunity: "anti-aging drug today" eight years later.Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).Melanoma in organ transplant recipients: incidence, outcomes and management considerations.Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin.Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes.Cancer in the transplant recipient.Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation.Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22.More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients.Gerosuppression by pan-mTOR inhibitors.Skin changes following organ transplantation: an interdisciplinary challenge.An evaluation of sirolimus in renal transplantation.Exploring new frontiers: sirolimus as a pharmacokinetic modulator in advanced cancer patients.Update on the long-term complications of renal transplantation.Malignancies after pediatric kidney transplantation: more than PTLD?Synergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients.

P2860

Q26748580-25F1FF9A-794A-49B0-B3EF-0CCA1FE2DDAA Q26799460-364BAE78-EF47-4C33-813B-D0593CCEF753 Q26799916-E754F32F-A081-4B57-B73D-9062470D1BEA Q26851436-EB240C0E-D080-4716-895A-773D9A75A816 Q26992343-9E799290-D7DF-42FE-9971-A3BECFB96995 Q27000107-C88D3AC7-F659-4F60-AF35-612ECBFC5260 Q28080955-15034306-0474-4B9A-B4E5-91C7D496514B Q28307873-EA70A50D-FC16-4E25-8A83-C7583A39F7F2 Q30580161-A9F0DEA9-1930-4453-8A40-C29AABF27260 Q30871643-9C7B920F-46B4-4343-BB74-F129C868D09B Q33412367-77EEFD7F-9CB0-4A72-8450-D034C56BD438 Q33829205-6E735238-EE8E-4C60-AE73-6794B4CF9A39 Q33838971-75273A45-AA9E-4AE6-AEFD-CFD339409C07 Q33873997-B8D73258-3D37-4D65-B813-72A7279E55EC Q33923227-BA41BAA9-C856-453F-98B0-6365936F72E4 Q34111987-BE5AD528-BC53-4BE2-B033-6D98C57C5F54 Q34268585-C70775DF-542C-4775-946F-32C3414566A3 Q34309887-A8195199-BA64-453E-A9FB-D6A42220F036 Q34392470-07D9A830-AFFC-47B4-BA32-EAC71B92C964 Q34805919-8F0E5494-508D-43C0-B6CD-3621B86CFF6D Q36023899-F998B60F-FD26-436F-A059-6D2E0A8B5877 Q36051817-E3E00105-FCE9-4040-BC29-E370A99E087F Q36209013-5874F59F-8998-46AE-AF06-ACE22B3DB5DC Q36260537-BC1C7312-DA5B-41A2-8F29-198E9D861C76 Q36414149-589B121A-F665-4983-9D79-E38AA6FEF0CD Q36440261-A49403F4-A7A1-448C-B9E2-AA67C9AFED95 Q36649878-04225665-7B10-4C61-B000-5ECB56B1E419 Q36926098-6CAAD1A5-1FBC-42D6-ACD0-FE7DBEC594D9 Q36938488-EAC5C3FF-5AB1-4E3A-80B6-DDE40E010B5E Q36964382-45AEA7E9-24D3-455B-BD30-D7794174FB30 Q37184425-EA2DC15A-2236-4307-B004-564291788431 Q37277272-1DADEFB6-305D-424E-B21F-EFEEE0E2A990 Q37522572-184D8BC8-7AEC-41B4-B181-D41C506D0D20 Q37610218-D88FA935-CCF6-45A6-9A60-72C47BB2598D Q37687958-CD888610-BD11-4BE9-A4D0-DF1D51ECF814 Q38038696-F0C23B7D-4C04-4D93-BEFE-25511116862F Q38069181-B19652A8-4017-4663-A9D8-7C4212A293D0 Q38104335-608D6CBB-A897-48D5-870A-BB8E7407B470 Q38141838-34001F41-E1AC-4A7C-9A79-46D974226CF8 Q38187197-B99C78AF-7433-4F4C-9222-41716806B50F

P2860

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

http://www.wikidata.org/entity/Q55056496

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

@en

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

@nl

type

label

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

@en

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

@nl

prefLabel

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

@en

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

@nl

P1433

Q55056496-971937DD-C67B-428E-8201-556B0F1D1761

P1476

Q55056496-EA876552-F32D-4CB9-BABC-DEE0162DE5DA

P2093

Q55056496-2468D211-1657-48D9-981A-F7C092D8C6F8

Q55056496-31499E2F-1182-4F97-9EE9-A49840545ABF

Q55056496-34C27627-C828-4140-8454-3C14F6763B81

Q55056496-34CB6B68-18FD-4330-85C7-4D0777ADC179

Q55056496-36CE66A8-1008-414C-89EE-481C0394FA80

Q55056496-5A23803F-2475-4788-8A7B-448B8479ADE7

Q55056496-6C7E1367-A3C8-4951-AE22-305BC7D20FF5

Q55056496-789FBB07-9EA9-4CA7-BA6D-C0D59F611D25

Q55056496-7B1BE2D8-5C76-4ECE-8A2F-764583034601

Q55056496-8404294B-3A3F-4D70-9904-91A95926D17F

P304

Q55056496-603BCFF4-85F6-416C-83AE-38BAD2417AC8

P31

Q55056496-29370341-122F-46F2-96DC-A616E655634C

P356

Q55056496-24B39D27-FC2B-4BC0-8A44-D14DA632DC57

P407

Q55056496-9135102D-E0EA-4248-918F-9F3E18B43688

P433

Q55056496-7E05F2D0-0F46-47AD-B738-84FAD4165D72

P478

Q55056496-A7AF138D-DC58-4888-865C-E0E7C365F5B4

P50

Q55056496-7EAD46F0-4E6B-456B-930B-BFE7413F7551

P577

Q55056496-8B511ABC-8C91-44B3-9531-29CE98A9033A

P698

Q55056496-171C46D7-755A-4D94-8959-26AF5D957788

P356

P1433

The New England Journal of Medicine

P1476

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

@en

P2093

Adeline S Roux

http://www.w3.org/2001/XMLSchema#string

Anabelle Brocard

http://www.w3.org/2001/XMLSchema#string

Andreas L Serra

http://www.w3.org/2001/XMLSchema#string

Anne Dompmartin

http://www.w3.org/2001/XMLSchema#string

Claire Pouteil-Noble

http://www.w3.org/2001/XMLSchema#string

Emmanuel Morelon

http://www.w3.org/2001/XMLSchema#string

Eric Goffin

http://www.w3.org/2001/XMLSchema#string

Evelyne Decullier

http://www.w3.org/2001/XMLSchema#string

Günther F L Hofbauer

http://www.w3.org/2001/XMLSchema#string

Isabelle Tromme

http://www.w3.org/2001/XMLSchema#string

P304

329-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1204166

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

367

http://www.w3.org/2001/XMLSchema#string

P50

Lionel Rostaing

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22830463

http://www.w3.org/2001/XMLSchema#string